Capricor Therapeutics
CAPR
CAPR
31 hedge funds and large institutions have $16.8M invested in Capricor Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.01% more ownership
Funds ownership: 10.46% → 11.47% (+1%)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
Holders
31
Holding in Top 10
–
Calls
$2.28M
Puts
$1.9M
Top Buyers
| 1 | +$830K | |
| 2 | +$315K | |
| 3 | +$225K | |
| 4 |
Millennium Management
New York
|
+$164K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$138K |
Top Sellers
| 1 | -$145K | |
| 2 | -$102K | |
| 3 | -$63.6K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$52K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$47.1K |